Pastāsti draugiem par šo preci:
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development N Ferrari
Cena
€ 214,49
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 18. sept. - . gada 2. okt.
Saņemiet paziņojumus par jauniem N Ferrari izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development
N Ferrari
Antisense-based drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer, diabetes, and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.
576 pages
| Mediji | Grāmatas Hardcover Book (Grāmata ar cieto muguriņu un vāku) |
| Izlaists | 2018. gada 31. jūlijs |
| ISBN13 | 9781118537336 |
| Izdevēji | John Wiley & Sons Inc |
| Lapas | 576 |
| Izmēri | 160 × 231 × 33 mm · 898 g |
| Valoda | Angļu |
| Redaktors | Ferrari, Nicolay |
| Redaktors | Seguin, Rosanne |
